“The Centers for Medicare & Medicaid Services (CMS) has selected Qlarant as the Investigations Medicare Drug Integrity Contractor (I-MEDIC) to detect, prevent, and proactively deter fraud, waste, and abuse (FWA) in Medicare Programs. This designation will allow Qlarant to perform these functions in the plans commonly known as Parts C & D…”
“Under CMS direction, Qlarant will perform various functions related to potential fraud, waste and abuse from prescribers, pharmacies, and beneficiaries. The primary focus will be on complaint intake and response, data analysis, assessing leads, investigative action, administrative actions and program integrity. The program is required to work in compliance with all federal and state laws, regulations, and CMS requirements…” Read the full press release here.
Source: CMS Selects Qlarant as the Investigations Medicare Drug Integrity Contractor to Detect, Prevent, and Deter Fraud, Waste, and Abuse, October 25, 2018. Qlarant.
